Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Immunotherapy with antigen presenting cells for metastatic breast and prostate cancer

April 6, 2004

Monoclonal antibody effective against cancer progression in vivo

April 5, 2004

WX-G250 plus IFNalpha-2a reported safe and effective in renal cell carcinoma

April 2, 2004

Development of an anti-IL-6 monoclonal antibody for metastatic renal cell carcinoma

March 30, 2004

SGN-40 enters phase I trial for multiple myeloma

March 29, 2004

Enhanced efficacy of chemotherapy when used with OncoVEX in tumor models

March 29, 2004

Active Biotech TTS candidate drug shows promise in pancreatic cancer

March 29, 2004

A HER-2 protein vaccine shows promise in breast cancer immunotherapy

March 29, 2004

HuMax-CD4 receives fast track designation for cutaneous T-cell lymphoma

March 25, 2004

MLN-2704 selected for CMA Pilot 2 Program

March 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...